These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26863893)

  • 1. Efficacy of three different pulpotomy agents in primary molars: a randomized control trial.
    Rajasekharan S; Martens LC; Vandenbulcke J; Jacquet W; Bottenberg P; Cauwels RG
    Int Endod J; 2017 Mar; 50(3):215-228. PubMed ID: 26863893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth.
    Çelik BN; Mutluay MS; Arıkan V; Sarı Ş
    Clin Oral Investig; 2019 Feb; 23(2):661-666. PubMed ID: 29744721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial.
    Nosrat A; Seifi A; Asgary S
    Int J Paediatr Dent; 2013 Jan; 23(1):56-63. PubMed ID: 22309243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Direct Pulp Capping by Using Either ProRoot Mineral Trioxide Aggregate or Biodentine in Permanent Teeth with Carious Pulp Exposure in 6- to 18-Year-Old Patients: A Randomized Controlled Trial.
    Parinyaprom N; Nirunsittirat A; Chuveera P; Na Lampang S; Srisuwan T; Sastraruji T; Bua-On P; Simprasert S; Khoipanich I; Sutharaphan T; Theppimarn S; Ue-Srichai N; Tangtrakooljaroen W; Chompu-Inwai P
    J Endod; 2018 Mar; 44(3):341-348. PubMed ID: 29275850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Pulp Responses to Partial Pulpotomy Treatment with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial.
    Bakhtiar H; Nekoofar MH; Aminishakib P; Abedi F; Naghi Moosavi F; Esnaashari E; Azizi A; Esmailian S; Ellini MR; Mesgarzadeh V; Sezavar M; About I
    J Endod; 2017 Nov; 43(11):1786-1791. PubMed ID: 28822566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: Clinical and radiographic study.
    Carti O; Oznurhan F
    Niger J Clin Pract; 2017 Dec; 20(12):1604-1609. PubMed ID: 29378994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2-year randomised clinical trial.
    Malekafzali B; Shekarchi F; Asgary S
    Eur J Paediatr Dent; 2011 Sep; 12(3):189-93. PubMed ID: 22077689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V; Courson F; Durieux P; Muller-Bolla M; Glenny AM; Fron Chabouis H
    Cochrane Database Syst Rev; 2014 Aug; (8):CD003220. PubMed ID: 25099759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Vital Pulp Therapy Using Mineral Trioxide Aggregate or Biodentine: A Prospective Randomized Clinical Trial.
    Awawdeh L; Al-Qudah A; Hamouri H; Chakra RJ
    J Endod; 2018 Nov; 44(11):1603-1609. PubMed ID: 30292451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars.
    Juneja P; Kulkarni S
    Eur Arch Paediatr Dent; 2017 Aug; 18(4):271-278. PubMed ID: 28780718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Radiographic Evaluation of Success of Two commercially Available Pulpotomy Agents in Primary Teeth: An in vivo Study.
    Togaru H; Muppa R; Srinivas N; Naveen K; Reddy VK; Rebecca VC
    J Contemp Dent Pract; 2016 Jul; 17(7):557-63. PubMed ID: 27595722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
    Alqaderi HE; Al-Mutawa SA; Qudeimat MA
    J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mineral trioxide aggregate and formocresol pulpotomy on vital primary teeth: a clinical and radiographic study.
    Olatosi OO; Sote EO; Orenuga OO
    Niger J Clin Pract; 2015; 18(2):292-6. PubMed ID: 25666010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An 18 month evaluation of MM-MTA pulpotomy on primary decayed molars].
    Abou Chedid JC; Mchayleh N; Khalil I; Melki B; Hardan LS
    Odontostomatol Trop; 2015 Dec; 38(152):17-24. PubMed ID: 26939217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial pulpotomy with two bioactive cements in permanent teeth of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial.
    Uesrichai N; Nirunsittirat A; Chuveera P; Srisuwan T; Sastraruji T; Chompu-Inwai P
    Int Endod J; 2019 Jun; 52(6):749-759. PubMed ID: 30638262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineral Trioxide Aggregate Partial Pulpotomy Versus Formocresol Pulpotomy: A Randomized, Split-Mouth, Controlled Clinical Trial with 24 Months Follow-Up.
    Nematollahi H; Noorollahian H; Bagherian A; Yarbakht M; Nematollahi S
    Pediatr Dent; 2018 May; 40(3):184-189. PubMed ID: 29793564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodentine used as a pulp-capping agent in primary pig teeth.
    Shayegan A; Jurysta C; Atash R; Petein M; Abbeele AV
    Pediatr Dent; 2012; 34(7):e202-8. PubMed ID: 23265156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.